Drugs / LDP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04739111 | Jan 2021 → Sep 2022 | cancer | Dragonboat Biopharmaceutical Company Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LDP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04739111 ↗ |
| Modality | Monoclonal antibody | “Human Anti-PD-L1 Monoclonal Antibody Injection (LDP)” NCT04739111 ↗ |